NF1 loss in estrogen receptor-positive breast cancer induces osteoclast formation and immunosuppression to promote bone metastasisZifan Zhao, Eric C. Chang, Yi-Hsuan Wu et al.|Cancer Letters|2026Cited by 1
Figures S1 through S19 from PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER<sup>+</sup> Breast CancerAnran Chen, Matthew J. Ellis, Byung-Sun Kim et al.|Figshare|2024Cited by 0